Anticancer drugs, immunosuppressants, ophthalmology drugs, drugs used for obstructive airway diseases, migraine treatments
EETED 674105-2026published across the EU
Machine translation. The official title is Kasvajavastased ravimid, immunosupressandid, oftalmoloogias kasutatavad ravimid, hingamisteede obstruktiivsete haiguste raviks kasutatavad ravimid, migreenivastased ravimid.
sihtasutus Põhja-Eesti Regionaalhaigla, based in Tallinn, has launched a tender for medical and lab supplies. The contract is estimated at €26,513,000. The buyer has split the job into 43 lots that are awarded separately, so you can bid for the ones that suit your company.
Because this is an open procedure, any qualified company is welcome to submit a bid. All bid documents must be written in Estonian or English and must arrive no later than 3 Nov 2026, 11:00.
Written from the facts of the notice. The official notice is the only binding text.
Our read
sihtasutus Põhja-Eesti Regionaalhaigla sees a completely standard level of bidding competition. Across 432 known contracts, they average 2.4 bids per tender, in line with the national average of 2.1 for this trade. Their latest award was a €14,642,000 contract (“Toidukaubad”), which went to Aktsiaselts Kaupmees & Ko, chosen from 4 bids. At €26,513,000, this tender is well above the typical €250,000 for this trade nationally. If it is too large for your company alone, you can bid together with a partner.
We base these figures on the award notices we collect: every one we hold for this buyer, plus the last twelve months of awards in this trade across the country.
Do you qualify?
Do not lose this contract over a missing document. GroundedBid reads the tender documents and lists what the buyer asks of you, each line with the page it comes from.